International Classification of Diseases for Oncology

From WikiMD's WELLNESSPEDIA

International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Classification of Diseases (ICD) for tumor diseases. This classification is widely used by cancer registries worldwide for the coding of histology, topography and the behavior of neoplasms. The ICD-O was first published by the World Health Organization (WHO) in 1976 and is currently in its third revision (ICD-O-3).

History[edit]

The ICD-O was developed in response to the need for a standardized system for classifying oncological diseases. The first edition was published in 1976, followed by the second edition in 1990. The third and current edition, ICD-O-3, was published in 2000 and has been updated periodically to reflect advances in our understanding of cancer.

Structure[edit]

The ICD-O uses a dual coding system to classify neoplasms by both their site (topography) and histology (morphology). The topography code uses the same structure as the ICD, with the addition of a letter to denote the side of the body. The morphology code is a five-digit number, with the first four digits representing the histological type of the tumor and the fifth digit representing its behavior (benign, malignant, in situ, etc.).

Usage[edit]

The ICD-O is used by cancer registries worldwide for the coding of histology, topography and the behavior of neoplasms. It is also used in clinical settings for the diagnosis and treatment of cancer, as well as in research to study the epidemiology and etiology of cancer.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.